Novo Nordisk Business Development Manager Salaries in Wilmington, DE
The average Novo Nordisk Business Development Manager in Wilmington, DE earns an estimated $156,634 annually, which includes an estimated base salary of $125,167 with a $31,467 bonus. Novo Nordisk's Business Development Manager compensation is $24,493 more than the US average for a Business Development Manager. Business Development Manager salaries at Novo Nordisk in Wilmington, DE can range from $55,000 - $306,000.
In Wilmington, DE, The Business Development Department at Novo Nordisk earns $1,769 more on average than the Marketing Department.
Last updated 8 months ago.
- $125,167
- avg. base
- $31,467
- avg. bonus
Business Development Manager Salaries at Novo Nordisk
In Wilmington, DE, Business Development Managers earn $2,512 more than Business Development Managers, and $51,650 less than Directors of Business Development.
Compensation at Novo Nordisk by Department
In Wilmington, DE, The Business Development Department averages $1,769 more than the Marketing Department, and $2,256 less than the Engineering Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Novo Nordisk reported making $151,865, while the average male Business Development Manager at similar sized companies reported making $160,499.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Business Development Manager at companies similar size to Novo Nordisk reported making $180,546, while the average African American/Black Business Development Manager at similar sized companies reported making $121,400.
How Business Development Managers at Novo Nordisk Rate Their Compensation
The majority of Business Development Managers at Novo Nordisk believe they're compensated fairly. 50% of Business Development Managers at Novo Nordisk say they receive annual bonuses, and the vast majority (84%) are satisfied with their benefits. See more compensation ratings at Novo Nordisk
